Reg Waldeck
Head, Global Market Access Bayer
Reg is currently the Head of Global Market Access at Bayer which includes team members responsible for Market Access, Pricing & Value Optimization and Health Economics & Outcomes Research. He is a biopharma leader with over 25 years experience in Pharma and Biotech in the US, Australia and global functions, with positions in Market Access, Pricing, Marketing, HEOR & Decision Analysis. Reg holds a PhD in Biophysical Chemistry as well as post-graduate training in Health Economics & Marketing
Seminars
Wednesday 28th October 2026
Why Strong Evidence Still Isn’t Enough & What It Takes to Secure Access, Pricing & Reimbursement in Today’s Market
10:00 am
- Understanding why robust clinical and real-world evidence still fails to translate into payer approval and favorable access outcomes
- Navigating the realities of pricing, policy, and reimbursement frameworks that influence decisions beyond the strength of the data
- Aligning evidence generation with payer expectations early to avoid delays, restrictions, and lost commercial value
